Entrada Therapeutics, Inc. (NASDAQ:TRDA – Get Free Report) Director Kush Parmar sold 114,756 shares of the firm’s stock in a transaction on Thursday, July 30th. The shares were sold at an average price of $6.93, for a total transaction of $795,259.08. Following the transaction, the director owned 2,848,310 shares in the company, valued at $19,738,788.30. […]